STOCKWATCH
·
Pharmaceuticals
Business Update31 Jan 2024, 01:00 am

GUFIC BIOSCIENCES LTD. GRANTED PATENT OF ADDITION

AI Summary

The company has been granted a patent of addition for a freeze-dried parenteral composition of omadacycline tosylate with improved stability for a term of 20 years effective from April 19, 2021.,

Key Highlights

  • Granted Patent of Addition
  • Improved Stability
  • 20-Year Term
GUFICBIO
Pharmaceuticals
GUFIC BIOSCIENCES LTD.

Price Impact